HUTCHMED (China) (HCM) Other Accumulated Expenses (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Other Accumulated Expenses came in at $26.9 million in Q4 2025, down 18.48% year-on-year from $32.9 million in Q4 2024, and up 424.89% on a QoQ basis from $5.1 million in Q2 2025.
HUTCHMED (China) (HCM) Other Accumulated Expenses (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Other Accumulated Expenses data on file, last reported at $26.9 million in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 18.48% year-over-year to $26.9 million in Q4 2025; TTM through Dec 2025 was $26.9 million, a 18.48% decrease from a year earlier, with the FY2025 full-year figure at $26.9 million, down 18.18% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $26.9 million, up from $5.1 million in the prior quarter.
- Over the last five years, Other Accumulated Expenses for HCM reached as high as $37.2 million in Q2 2022 and fell as low as $2.1 million in Q4 2022.
- Historically, Other Accumulated Expenses has averaged $13.5 million across 5 years, with a median of $6.8 million in 2023.
- Across the five-year window, Other Accumulated Expenses plunged 87.78% in 2022 and jumped 1423.84% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $17.2 million in 2021, then plunged by 87.78% to $2.1 million in 2022, then grew by 2.9% to $2.2 million in 2023, then soared by 1423.84% to $32.9 million in 2024, then dropped by 18.48% to $26.9 million in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $26.9 million in Q4 2025, $5.1 million in Q2 2025, and $32.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.86 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Dec 31, 2024 | 32.95 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Jun 30, 2022 | 37.25 Mn |
| Dec 31, 2021 | 17.19 Mn |
| Jun 30, 2021 | 6.86 Mn |
| Mar 31, 2021 | 5.58 Mn |
| Dec 31, 2020 | 4.38 Mn |
| Jun 30, 2020 | 3.93 Mn |
| Dec 31, 2019 | 5.86 Mn |
| Sep 30, 2019 | 4.07 Mn |
| Jun 30, 2019 | 5.36 Mn |
| Mar 31, 2019 | 3.21 Mn |
| Dec 31, 2018 | 26.61 Mn |
| Dec 31, 2017 | 3.57 Mn |
| Jun 30, 2017 | 1.52 Mn |